SBRX2

SBRX2 is a plant-based drug candidate being developed by Stramsen Biotech for the treatment of fever, flu, allergies, and viral respiratory infections. Part of the company's SBRX series, the drug is derived from a proprietary database of several thousand medicinal plants. Stramsen Biotech, a Texas-based biopharmaceutical company, focuses on developing natural therapeutics for a wide range of conditions, including respiratory and infectious diseases. While SBRX2 is part of a pipeline that includes candidates in early-stage clinical trials, specific molecular targets and detailed clinical data for this candidate have not been publicly disclosed.